Skip to main content
. 2011 Jan;163(1):65–76. doi: 10.1111/j.1365-2249.2010.04250.x

Fig. 2.

Fig. 2

(a) Interferon (IFN)-γ expression in supernatants of biopsies from healthy controls and from non-inflamed areas of patients with inflammatory bowel disease (IBD) using enzyme-linked immunosorbent assay (ELISA). (b) IFN-γ expression in supernatants of biopsies from non-inflamed and inflamed areas of patients with Crohn's disease. (c) IFN-γ expression in supernatants of biopsies from non-inflamed and inflamed areas of patients with ulcerative colitis.